STEVEN A SHALLCROSS
CIK 1263501 · CEO and CFO · last filed 2026-01-06
STEVEN A SHALLCROSS is a CEO and CFO who has filed 43 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for TOVX, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$505.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $76.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$76.0K
5
43
-$505.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TOVX | CEO and CFO | 250,000 | $0.30 | $76.0K | $160.0K | 11 | 2026-01-06 |
| ELYS | Director | 27,717 | $0.00 | $3 | $0 | 3 | 2023-02-16 |
| Theriva Biologics, Inc. (SYN) Delisted | CEO and CFO | 100,000 | $1.02 | $102.0K | $45.4K | 10 | 2021-12-27 |
| VEEE | Director | — | $5.67 | — | $0 | 1 | 2021-07-26 |
| VNDA | Sr. VP, CFO, Treasurer | 0 | $5.87 | $0 | -$711.2K | 13 | 2008-01-08 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | TOVX | Grant (A) | — | $0 | EDGAR |
| 2025-05-01 | TOVX | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | TOVX | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | TOVX | Buy (P) | +14,000 | $9.7K | EDGAR |
| 2023-06-07 | TOVX | Buy (P) | +26,000 | $16.5K | EDGAR |
| 2023-02-16 | ELYS | Grant (A) | +22,472 | $20.0K | EDGAR |
| 2023-02-13 | TOVX | Buy (P) | +25,000 | $26.1K | EDGAR |
| 2023-02-03 | TOVX | Buy (P) | +25,000 | $23.5K | EDGAR |
| 2023-01-26 | TOVX | Buy (P) | +25,000 | $21.8K | EDGAR |
| 2023-01-23 | TOVX | Buy (P) | +25,000 | $18.7K | EDGAR |